Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Long-Term Follow-up Study of the Phase I/II Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Sponsor: StemCells, Inc.
Terminated
Based on a business decision unrelated to any safety concerns.
Other terminated trials from StemCells, Inc.
- Spinal Cord Injury · May 2016
- Cervical Spinal Cord Injury · Phase PHASE2 · May 2016
- Age-Related Macular Degeneration · Phase PHASE2 · May 2016
More terminations from StemCells, Inc.
Other Age-Related Macular Degeneration trials with similar outcome
A observational or N/A phase clinical study on Age-Related Macular Degeneration and Geographic Atrophy, this trial is terminated or withdrawn. The trial is conducted by StemCells, Inc. and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- StemCells, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .